Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 11Lymphoma, Follicular 10Leukemia, Lymphocytic, Chronic, B-Cell 10Burkitt Lymphoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Non-Hodgkin 9Lymphoma, Mantle-Cell 9Waldenstrom Macroglobulinemia 8Lymphoma 8Lymphoma, Large-Cell, Immunoblastic 6Leukemia 4Leukemia, Myeloid, Acute 3Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, B-Cell 2Lung Neoplasms 2Leukemia, Hairy Cell 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1

Interventions

Etoposide 154Carboplatin 142Cisplatin 104Topotecan 74durvalumab 48atezolizumab 46Irinotecan 44pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 29anlotinib 23PM 01183 22Gemcitabine 21Drug Therapy 20apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Bevacizumab 13amrubicin 11Magnetic Resonance Spectroscopy 11Cyclophosphamide 11rovalpituzumab tesirine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Small Cell Lung Carcinoma × Indium × Clear all
NCT00006347 2009-03-03

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡